

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of synapse structural plasticity (GO:0051823) | 6.37590978 |
| 2 | prepulse inhibition (GO:0060134) | 6.15542910 |
| 3 | synaptic transmission, dopaminergic (GO:0001963) | 6.09740780 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.95785830 |
| 5 | locomotory exploration behavior (GO:0035641) | 5.72384868 |
| 6 | synaptic vesicle maturation (GO:0016188) | 5.68000015 |
| 7 | adenosine receptor signaling pathway (GO:0001973) | 5.50509257 |
| 8 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.48409634 |
| 9 | striatum development (GO:0021756) | 5.27015872 |
| 10 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 5.12236526 |
| 11 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 5.07911200 |
| 12 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.00391099 |
| 13 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.94822682 |
| 14 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.92176941 |
| 15 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.90031736 |
| 16 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.86113648 |
| 17 | auditory behavior (GO:0031223) | 4.83655646 |
| 18 | vocalization behavior (GO:0071625) | 4.83625272 |
| 19 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.80384446 |
| 20 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 4.63646214 |
| 21 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 4.62631390 |
| 22 | dopamine receptor signaling pathway (GO:0007212) | 4.60858998 |
| 23 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 4.58076170 |
| 24 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.49562414 |
| 25 | regulation of dendritic spine morphogenesis (GO:0061001) | 4.44528060 |
| 26 | L-amino acid import (GO:0043092) | 4.40735818 |
| 27 | positive regulation of neurotransmitter transport (GO:0051590) | 4.38584347 |
| 28 | behavioral response to cocaine (GO:0048148) | 4.37105475 |
| 29 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 4.36165390 |
| 30 | neuromuscular process controlling balance (GO:0050885) | 4.35958395 |
| 31 | synaptic vesicle exocytosis (GO:0016079) | 4.33379678 |
| 32 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.32224331 |
| 33 | response to auditory stimulus (GO:0010996) | 4.27979594 |
| 34 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.24383929 |
| 35 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.17399556 |
| 36 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 4.16458931 |
| 37 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 4.16458931 |
| 38 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 4.12185683 |
| 39 | substrate-independent telencephalic tangential migration (GO:0021826) | 4.12185683 |
| 40 | dendritic spine morphogenesis (GO:0060997) | 4.09726769 |
| 41 | * response to amphetamine (GO:0001975) | 4.08471949 |
| 42 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 4.07984852 |
| 43 | neuron-neuron synaptic transmission (GO:0007270) | 4.07628239 |
| 44 | regulation of female receptivity (GO:0045924) | 4.06796560 |
| 45 | neurotransmitter secretion (GO:0007269) | 4.06613522 |
| 46 | long-term memory (GO:0007616) | 4.04623542 |
| 47 | exploration behavior (GO:0035640) | 4.00164247 |
| 48 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.99827893 |
| 49 | protein localization to synapse (GO:0035418) | 3.98402798 |
| 50 | cellular potassium ion homeostasis (GO:0030007) | 3.98289027 |
| 51 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.92348721 |
| 52 | regulation of glutamate secretion (GO:0014048) | 3.92094990 |
| 53 | positive regulation of membrane potential (GO:0045838) | 3.91902300 |
| 54 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.88785926 |
| 55 | neuronal action potential propagation (GO:0019227) | 3.87218952 |
| 56 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.84131252 |
| 57 | neuronal ion channel clustering (GO:0045161) | 3.81947811 |
| 58 | synaptic transmission, glutamatergic (GO:0035249) | 3.81935812 |
| 59 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.81536457 |
| 60 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.79453239 |
| 61 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.76488963 |
| 62 | regulation of neurotransmitter uptake (GO:0051580) | 3.75330404 |
| 63 | layer formation in cerebral cortex (GO:0021819) | 3.74990368 |
| 64 | regulation of synaptic vesicle transport (GO:1902803) | 3.74925497 |
| 65 | transmission of nerve impulse (GO:0019226) | 3.74367432 |
| 66 | neurotransmitter transport (GO:0006836) | 3.71873110 |
| 67 | regulation of synaptic plasticity (GO:0048167) | 3.70402523 |
| 68 | gamma-aminobutyric acid transport (GO:0015812) | 3.67431636 |
| 69 | regulation of postsynaptic membrane potential (GO:0060078) | 3.66011852 |
| 70 | activation of protein kinase A activity (GO:0034199) | 3.62733167 |
| 71 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.61571169 |
| 72 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.59752496 |
| 73 | peristalsis (GO:0030432) | 3.57579213 |
| 74 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.56577386 |
| 75 | * regulation of neurotransmitter levels (GO:0001505) | 3.55225297 |
| 76 | regulation of neurotransmitter secretion (GO:0046928) | 3.53965291 |
| 77 | response to histamine (GO:0034776) | 3.53638007 |
| 78 | female mating behavior (GO:0060180) | 3.53116035 |
| 79 | behavioral fear response (GO:0001662) | 3.51442171 |
| 80 | behavioral defense response (GO:0002209) | 3.51442171 |
| 81 | glutamate receptor signaling pathway (GO:0007215) | 3.51240664 |
| 82 | sodium ion export (GO:0071436) | 3.50206035 |
| 83 | mechanosensory behavior (GO:0007638) | 3.49842201 |
| 84 | glutamate secretion (GO:0014047) | 3.48758943 |
| 85 | negative regulation of dendrite development (GO:2000171) | 3.47588103 |
| 86 | glycine transport (GO:0015816) | 3.45958443 |
| 87 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.45798688 |
| 88 | positive regulation of dendritic spine development (GO:0060999) | 3.45013183 |
| 89 | proline transport (GO:0015824) | 3.43946959 |
| 90 | regulation of protein kinase A signaling (GO:0010738) | 3.43906964 |
| 91 | membrane hyperpolarization (GO:0060081) | 3.43210005 |
| 92 | long-term synaptic potentiation (GO:0060291) | 3.42465626 |
| 93 | positive regulation of synapse maturation (GO:0090129) | 3.41836481 |
| 94 | regulation of dendritic spine development (GO:0060998) | 3.39061849 |
| 95 | postsynaptic membrane organization (GO:0001941) | 3.38045039 |
| 96 | amino acid import (GO:0043090) | 3.36294985 |
| 97 | cerebellar granule cell differentiation (GO:0021707) | 3.35489345 |
| 98 | regulation of Rap GTPase activity (GO:0032317) | 3.32500671 |
| 99 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.31313243 |
| 100 | central nervous system myelination (GO:0022010) | 3.28644411 |
| 101 | axon ensheathment in central nervous system (GO:0032291) | 3.28644411 |
| 102 | mating behavior (GO:0007617) | 3.27041948 |
| 103 | * visual learning (GO:0008542) | 3.25590463 |
| 104 | negative regulation of amino acid transport (GO:0051956) | 3.24942263 |
| 105 | cAMP biosynthetic process (GO:0006171) | 3.22082422 |
| 106 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 3.21431982 |
| 107 | regulation of norepinephrine secretion (GO:0014061) | 3.19919128 |
| 108 | positive regulation of synaptic transmission (GO:0050806) | 3.19451994 |
| 109 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.18338085 |
| 110 | neuromuscular process (GO:0050905) | 3.17611543 |
| 111 | membrane depolarization (GO:0051899) | 3.16923014 |
| 112 | neuromuscular process controlling posture (GO:0050884) | 3.14754317 |
| 113 | regulation of ARF protein signal transduction (GO:0032012) | 3.14512884 |
| 114 | regulation of neurotransmitter transport (GO:0051588) | 3.13392992 |
| 115 | drinking behavior (GO:0042756) | 3.12721888 |
| 116 | potassium ion import (GO:0010107) | 3.12097157 |
| 117 | regulation of synapse maturation (GO:0090128) | 3.11946252 |
| 118 | membrane depolarization during action potential (GO:0086010) | 3.10152125 |
| 119 | vesicle transport along microtubule (GO:0047496) | 3.09342922 |
| 120 | * cAMP catabolic process (GO:0006198) | 3.08249471 |
| 121 | fear response (GO:0042596) | 3.07858700 |
| 122 | regulation of vesicle fusion (GO:0031338) | 3.05587656 |
| 123 | neuron cell-cell adhesion (GO:0007158) | 3.03725825 |
| 124 | synaptic vesicle endocytosis (GO:0048488) | 2.99172377 |
| 125 | synaptic transmission (GO:0007268) | 2.95479703 |
| 126 | neuromuscular synaptic transmission (GO:0007274) | 2.91548940 |
| 127 | alanine transport (GO:0032328) | 2.91281566 |
| 128 | acidic amino acid transport (GO:0015800) | 2.86494912 |
| 129 | adult walking behavior (GO:0007628) | 2.83887975 |
| 130 | regulation of synaptic transmission (GO:0050804) | 2.83374179 |
| 131 | * serotonin metabolic process (GO:0042428) | 2.82554776 |
| 132 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.80157773 |
| 133 | detection of calcium ion (GO:0005513) | 2.79630387 |
| 134 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.77965124 |
| 135 | potassium ion transmembrane transport (GO:0071805) | 2.77921373 |
| 136 | cellular potassium ion transport (GO:0071804) | 2.77921373 |
| 137 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.76389072 |
| 138 | cell differentiation in hindbrain (GO:0021533) | 2.73297024 |
| 139 | regulation of exocytosis (GO:0017157) | 2.73082136 |
| 140 | potassium ion homeostasis (GO:0055075) | 2.65042488 |
| 141 | * primary amino compound metabolic process (GO:1901160) | 2.64298580 |
| 142 | neurotransmitter uptake (GO:0001504) | 2.63851933 |
| 143 | chemosensory behavior (GO:0007635) | 2.62967892 |
| 144 | behavioral response to nicotine (GO:0035095) | 2.62170439 |
| 145 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.60380560 |
| 146 | dendritic spine organization (GO:0097061) | 2.58738478 |
| 147 | establishment of synaptic vesicle localization (GO:0097480) | 2.55999001 |
| 148 | synaptic vesicle transport (GO:0048489) | 2.55999001 |
| 149 | potassium ion transport (GO:0006813) | 2.54181029 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.83430258 |
| 2 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 4.24073710 |
| 3 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 3.22134296 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.06321888 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.03237800 |
| 6 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.97339338 |
| 7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.90908015 |
| 8 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.76288819 |
| 9 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.72439276 |
| 10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.71445031 |
| 11 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.71445031 |
| 12 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.70098816 |
| 13 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.63315359 |
| 14 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.57496037 |
| 15 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.57255843 |
| 16 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.55338694 |
| 17 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.55213630 |
| 18 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.48557925 |
| 19 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.33132075 |
| 20 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.31604693 |
| 21 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.31556491 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.24162366 |
| 23 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.16798848 |
| 24 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.14344479 |
| 25 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.03609716 |
| 26 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.00181829 |
| 27 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.93223144 |
| 28 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.82463341 |
| 29 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.78596974 |
| 30 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.71832615 |
| 31 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.61558992 |
| 32 | KDM2B_26808549_Chip-Seq_K562_Human | 1.60571550 |
| 33 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.58279444 |
| 34 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.53782997 |
| 35 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.47393494 |
| 36 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.46419041 |
| 37 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.45779612 |
| 38 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.45698401 |
| 39 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.43770892 |
| 40 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.43191266 |
| 41 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.41796819 |
| 42 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.41196626 |
| 43 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.38758911 |
| 44 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.33417515 |
| 45 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.30672619 |
| 46 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.28268705 |
| 47 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.24517582 |
| 48 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.24517582 |
| 49 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.24106575 |
| 50 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.22839789 |
| 51 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.22417484 |
| 52 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.21285674 |
| 53 | AR_19668381_ChIP-Seq_PC3_Human | 1.20603671 |
| 54 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.20231578 |
| 55 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.19919874 |
| 56 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.19471116 |
| 57 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18133883 |
| 58 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.13814343 |
| 59 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.13309358 |
| 60 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.12900728 |
| 61 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.12176547 |
| 62 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.12149983 |
| 63 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.11492695 |
| 64 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10968021 |
| 65 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.10937756 |
| 66 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.10042944 |
| 67 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.07452761 |
| 68 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.07381323 |
| 69 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.07118081 |
| 70 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.06523658 |
| 71 | STAT3_23295773_ChIP-Seq_U87_Human | 1.06227031 |
| 72 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.05197757 |
| 73 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.05018459 |
| 74 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.03827990 |
| 75 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.02204575 |
| 76 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.02038284 |
| 77 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.01133021 |
| 78 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.00013399 |
| 79 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.99831880 |
| 80 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.98035863 |
| 81 | RXR_22108803_ChIP-Seq_LS180_Human | 0.97752525 |
| 82 | * KLF4_19829295_ChIP-Seq_ESCs_Human | 0.97188975 |
| 83 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.96342553 |
| 84 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.95460671 |
| 85 | VDR_22108803_ChIP-Seq_LS180_Human | 0.95327685 |
| 86 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.94072523 |
| 87 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.94004465 |
| 88 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.93198963 |
| 89 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.92251057 |
| 90 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.91833334 |
| 91 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.91342931 |
| 92 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.91197045 |
| 93 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.89694159 |
| 94 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.88983444 |
| 95 | TCF4_23295773_ChIP-Seq_U87_Human | 0.88788893 |
| 96 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.88768082 |
| 97 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.87425867 |
| 98 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.86570062 |
| 99 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.85884907 |
| 100 | AR_25329375_ChIP-Seq_VCAP_Human | 0.85379290 |
| 101 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.85285250 |
| 102 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.84972578 |
| 103 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.84468059 |
| 104 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.84155644 |
| 105 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.84105196 |
| 106 | * TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.83953226 |
| 107 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.81680077 |
| 108 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.80727054 |
| 109 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.80524577 |
| 110 | P300_19829295_ChIP-Seq_ESCs_Human | 0.79783321 |
| 111 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.79554228 |
| 112 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.79375003 |
| 113 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.78337434 |
| 114 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.78300851 |
| 115 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.78230671 |
| 116 | KDM2B_26808549_Chip-Seq_REH_Human | 0.77759939 |
| 117 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.77239684 |
| 118 | TP53_16413492_ChIP-PET_HCT116_Human | 0.77147196 |
| 119 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.77108953 |
| 120 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.76577574 |
| 121 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.75699030 |
| 122 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.75674503 |
| 123 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.75515582 |
| 124 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.75087037 |
| 125 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.73603778 |
| 126 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.72364546 |
| 127 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71113556 |
| 128 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.71061150 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002822_catalepsy | 9.12830734 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 6.62031598 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.12620073 |
| 4 | MP0003880_abnormal_central_pattern | 4.10865564 |
| 5 | MP0009745_abnormal_behavioral_response | 3.73176948 |
| 6 | * MP0002063_abnormal_learning/memory/cond | 3.41892315 |
| 7 | MP0004270_analgesia | 3.16662632 |
| 8 | MP0002064_seizures | 3.04321874 |
| 9 | MP0009046_muscle_twitch | 2.85368375 |
| 10 | MP0001486_abnormal_startle_reflex | 2.74041697 |
| 11 | * MP0002572_abnormal_emotion/affect_behav | 2.68319782 |
| 12 | MP0001529_abnormal_vocalization | 2.66791160 |
| 13 | MP0005423_abnormal_somatic_nervous | 2.55511243 |
| 14 | MP0002909_abnormal_adrenal_gland | 2.51308281 |
| 15 | MP0002272_abnormal_nervous_system | 2.42394641 |
| 16 | MP0001968_abnormal_touch/_nociception | 2.41739035 |
| 17 | MP0005646_abnormal_pituitary_gland | 2.21839832 |
| 18 | MP0001501_abnormal_sleep_pattern | 2.09985315 |
| 19 | MP0002734_abnormal_mechanical_nocicepti | 1.99538885 |
| 20 | MP0005386_behavior/neurological_phenoty | 1.92166289 |
| 21 | MP0004924_abnormal_behavior | 1.92166289 |
| 22 | MP0005409_darkened_coat_color | 1.80173491 |
| 23 | MP0008569_lethality_at_weaning | 1.76086382 |
| 24 | MP0001970_abnormal_pain_threshold | 1.74971635 |
| 25 | MP0004811_abnormal_neuron_physiology | 1.74734086 |
| 26 | MP0002638_abnormal_pupillary_reflex | 1.72603063 |
| 27 | MP0002733_abnormal_thermal_nociception | 1.68341984 |
| 28 | MP0003075_altered_response_to | 1.66837130 |
| 29 | MP0001984_abnormal_olfaction | 1.62446900 |
| 30 | MP0002557_abnormal_social/conspecific_i | 1.62403736 |
| 31 | MP0002736_abnormal_nociception_after | 1.58532943 |
| 32 | MP0000569_abnormal_digit_pigmentation | 1.57213962 |
| 33 | MP0001440_abnormal_grooming_behavior | 1.51039103 |
| 34 | MP0009780_abnormal_chondrocyte_physiolo | 1.50449763 |
| 35 | MP0001986_abnormal_taste_sensitivity | 1.49356126 |
| 36 | MP0005167_abnormal_blood-brain_barrier | 1.49336796 |
| 37 | MP0002067_abnormal_sensory_capabilities | 1.43394003 |
| 38 | MP0003633_abnormal_nervous_system | 1.38926567 |
| 39 | MP0008874_decreased_physiological_sensi | 1.38287186 |
| 40 | MP0003879_abnormal_hair_cell | 1.36474975 |
| 41 | MP0004885_abnormal_endolymph | 1.35781185 |
| 42 | MP0001188_hyperpigmentation | 1.31231242 |
| 43 | MP0003329_amyloid_beta_deposits | 1.31130683 |
| 44 | MP0008872_abnormal_physiological_respon | 1.26242534 |
| 45 | MP0001177_atelectasis | 1.25246880 |
| 46 | * MP0002066_abnormal_motor_capabilities/c | 1.24335691 |
| 47 | MP0000955_abnormal_spinal_cord | 1.23541744 |
| 48 | MP0003724_increased_susceptibility_to | 1.22648632 |
| 49 | MP0001905_abnormal_dopamine_level | 1.18096248 |
| 50 | MP0002184_abnormal_innervation | 1.17728305 |
| 51 | MP0008961_abnormal_basal_metabolism | 1.16433348 |
| 52 | MP0002735_abnormal_chemical_nociception | 1.16130185 |
| 53 | MP0008877_abnormal_DNA_methylation | 1.15032776 |
| 54 | MP0003690_abnormal_glial_cell | 1.15006998 |
| 55 | MP0004858_abnormal_nervous_system | 1.14828304 |
| 56 | MP0010234_abnormal_vibrissa_follicle | 1.13303796 |
| 57 | MP0002882_abnormal_neuron_morphology | 1.10901154 |
| 58 | MP0000013_abnormal_adipose_tissue | 1.10131176 |
| 59 | MP0005670_abnormal_white_adipose | 1.06769400 |
| 60 | MP0003631_nervous_system_phenotype | 1.06066282 |
| 61 | MP0005671_abnormal_response_to | 1.05741328 |
| 62 | MP0003283_abnormal_digestive_organ | 1.03396960 |
| 63 | MP0000778_abnormal_nervous_system | 1.01892702 |
| 64 | MP0002090_abnormal_vision | 0.95916764 |
| 65 | MP0001502_abnormal_circadian_rhythm | 0.95570662 |
| 66 | MP0004085_abnormal_heartbeat | 0.95275114 |
| 67 | MP0003787_abnormal_imprinting | 0.94427253 |
| 68 | MP0002069_abnormal_eating/drinking_beha | 0.92977661 |
| 69 | MP0005535_abnormal_body_temperature | 0.90614546 |
| 70 | MP0000920_abnormal_myelination | 0.89122589 |
| 71 | MP0002152_abnormal_brain_morphology | 0.87549954 |
| 72 | MP0003122_maternal_imprinting | 0.87415796 |
| 73 | MP0004142_abnormal_muscle_tone | 0.86145710 |
| 74 | MP0003011_delayed_dark_adaptation | 0.83239509 |
| 75 | MP0003436_decreased_susceptibility_to | 0.77131451 |
| 76 | MP0003172_abnormal_lysosome_physiology | 0.76782702 |
| 77 | MP0005645_abnormal_hypothalamus_physiol | 0.76158563 |
| 78 | MP0005499_abnormal_olfactory_system | 0.75835230 |
| 79 | MP0005394_taste/olfaction_phenotype | 0.75835230 |
| 80 | MP0005000_abnormal_immune_tolerance | 0.74353761 |
| 81 | MP0002229_neurodegeneration | 0.73450196 |
| 82 | MP0003634_abnormal_glial_cell | 0.73379829 |
| 83 | MP0001790_abnormal_immune_system | 0.73086481 |
| 84 | MP0005387_immune_system_phenotype | 0.73086481 |
| 85 | MP0002653_abnormal_ependyma_morphology | 0.72539261 |
| 86 | MP0010386_abnormal_urinary_bladder | 0.71965951 |
| 87 | MP0005166_decreased_susceptibility_to | 0.71336253 |
| 88 | MP0000604_amyloidosis | 0.70813546 |
| 89 | MP0000751_myopathy | 0.70662064 |
| 90 | MP0003303_peritoneal_inflammation | 0.69764517 |
| 91 | MP0001800_abnormal_humoral_immune | 0.69599891 |
| 92 | MP0002419_abnormal_innate_immunity | 0.68194318 |
| 93 | MP0002876_abnormal_thyroid_physiology | 0.67277524 |
| 94 | MP0002723_abnormal_immune_serum | 0.65751787 |
| 95 | MP0002971_abnormal_brown_adipose | 0.65554980 |
| 96 | MP0004147_increased_porphyrin_level | 0.63945618 |
| 97 | MP0003137_abnormal_impulse_conducting | 0.62551054 |
| 98 | MP0000631_abnormal_neuroendocrine_gland | 0.60821071 |
| 99 | MP0002420_abnormal_adaptive_immunity | 0.58340693 |
| 100 | MP0003045_fibrosis | 0.57906579 |
| 101 | MP0005025_abnormal_response_to | 0.57466334 |
| 102 | MP0003632_abnormal_nervous_system | 0.57308128 |
| 103 | MP0006082_CNS_inflammation | 0.57238871 |
| 104 | MP0001819_abnormal_immune_cell | 0.56632872 |
| 105 | MP0002148_abnormal_hypersensitivity_rea | 0.54882072 |
| 106 | MP0010329_abnormal_lipoprotein_level | 0.54058121 |
| 107 | MP0005551_abnormal_eye_electrophysiolog | 0.51495852 |
| 108 | MP0001664_abnormal_digestion | 0.48272657 |
| 109 | MP0006276_abnormal_autonomic_nervous | 0.46732296 |
| 110 | MP0004510_myositis | 0.46561886 |
| 111 | MP0004742_abnormal_vestibular_system | 0.44763977 |
| 112 | MP0001943_abnormal_respiration | 0.44454903 |
| 113 | MP0003956_abnormal_body_size | 0.44081658 |
| 114 | MP0001485_abnormal_pinna_reflex | 0.42266609 |
| 115 | MP0000003_abnormal_adipose_tissue | 0.41594508 |
| 116 | MP0010769_abnormal_survival | 0.40271990 |
| 117 | MP0004043_abnormal_pH_regulation | 0.39239634 |
| 118 | MP0010770_preweaning_lethality | 0.37838882 |
| 119 | MP0002082_postnatal_lethality | 0.37838882 |
| 120 | MP0003300_gastrointestinal_ulcer | 0.37718360 |
| 121 | MP0010768_mortality/aging | 0.37112997 |
| 122 | MP0002752_abnormal_somatic_nervous | 0.36314500 |
| 123 | MP0004130_abnormal_muscle_cell | 0.34414241 |
| 124 | MP0001963_abnormal_hearing_physiology | 0.31293732 |
| 125 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.31088471 |
| 126 | MP0005448_abnormal_energy_balance | 0.30478725 |
| 127 | MP0005310_abnormal_salivary_gland | 0.30364260 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 9.52784900 |
| 2 | Focal motor seizures (HP:0011153) | 7.52663314 |
| 3 | Focal seizures (HP:0007359) | 5.70448858 |
| 4 | Annular pancreas (HP:0001734) | 4.66512715 |
| 5 | Resting tremor (HP:0002322) | 4.61362942 |
| 6 | Torticollis (HP:0000473) | 4.51649190 |
| 7 | Visual hallucinations (HP:0002367) | 4.26288229 |
| 8 | Poor eye contact (HP:0000817) | 4.07257377 |
| 9 | Ankle clonus (HP:0011448) | 4.06872861 |
| 10 | Action tremor (HP:0002345) | 4.04039644 |
| 11 | Focal dystonia (HP:0004373) | 3.86145097 |
| 12 | Anxiety (HP:0000739) | 3.81268771 |
| 13 | Craniofacial dystonia (HP:0012179) | 3.78729060 |
| 14 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.78063112 |
| 15 | Depression (HP:0000716) | 3.74400841 |
| 16 | Abnormal social behavior (HP:0012433) | 3.72998614 |
| 17 | Impaired social interactions (HP:0000735) | 3.72998614 |
| 18 | Ankyloglossia (HP:0010296) | 3.52246134 |
| 19 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.47593044 |
| 20 | Epileptic encephalopathy (HP:0200134) | 3.42134505 |
| 21 | Dysdiadochokinesis (HP:0002075) | 3.41585468 |
| 22 | Generalized tonic-clonic seizures (HP:0002069) | 3.40181134 |
| 23 | Broad-based gait (HP:0002136) | 3.39691240 |
| 24 | Febrile seizures (HP:0002373) | 3.38199065 |
| 25 | Pointed chin (HP:0000307) | 3.30179224 |
| 26 | Postural instability (HP:0002172) | 3.25107579 |
| 27 | Papilledema (HP:0001085) | 3.23941965 |
| 28 | Absence seizures (HP:0002121) | 3.22804089 |
| 29 | Gaze-evoked nystagmus (HP:0000640) | 3.18105310 |
| 30 | Urinary urgency (HP:0000012) | 3.17170376 |
| 31 | Stereotypic behavior (HP:0000733) | 3.16632956 |
| 32 | Lower limb amyotrophy (HP:0007210) | 3.15856106 |
| 33 | Supranuclear gaze palsy (HP:0000605) | 3.05485012 |
| 34 | Dialeptic seizures (HP:0011146) | 3.05204134 |
| 35 | Dysmetria (HP:0001310) | 2.99741068 |
| 36 | Dysmetric saccades (HP:0000641) | 2.97476486 |
| 37 | Scanning speech (HP:0002168) | 2.96625981 |
| 38 | Polygenic inheritance (HP:0010982) | 2.93199358 |
| 39 | Progressive cerebellar ataxia (HP:0002073) | 2.85680110 |
| 40 | Polyphagia (HP:0002591) | 2.84935547 |
| 41 | Prolonged QT interval (HP:0001657) | 2.84749470 |
| 42 | Atonic seizures (HP:0010819) | 2.84723400 |
| 43 | Truncal ataxia (HP:0002078) | 2.82891896 |
| 44 | Abnormal eating behavior (HP:0100738) | 2.78743675 |
| 45 | Spastic gait (HP:0002064) | 2.73140937 |
| 46 | Atrioventricular block (HP:0001678) | 2.72212847 |
| 47 | Impaired smooth pursuit (HP:0007772) | 2.67553582 |
| 48 | Abnormality of oral frenula (HP:0000190) | 2.66917533 |
| 49 | Intention tremor (HP:0002080) | 2.65334350 |
| 50 | Abnormal EKG (HP:0003115) | 2.63837426 |
| 51 | Bradykinesia (HP:0002067) | 2.59136966 |
| 52 | Distal lower limb amyotrophy (HP:0008944) | 2.57931751 |
| 53 | Mutism (HP:0002300) | 2.57277920 |
| 54 | Impaired vibratory sensation (HP:0002495) | 2.56112167 |
| 55 | Megalencephaly (HP:0001355) | 2.53040380 |
| 56 | Abnormality of the lower motor neuron (HP:0002366) | 2.48322426 |
| 57 | Upper limb amyotrophy (HP:0009129) | 2.46959466 |
| 58 | Distal upper limb amyotrophy (HP:0007149) | 2.46959466 |
| 59 | Clonus (HP:0002169) | 2.46395811 |
| 60 | Limb dystonia (HP:0002451) | 2.40613479 |
| 61 | Hemiplegia (HP:0002301) | 2.37039477 |
| 62 | Heart block (HP:0012722) | 2.34478568 |
| 63 | Stomatitis (HP:0010280) | 2.34286213 |
| 64 | Ventricular fibrillation (HP:0001663) | 2.32461260 |
| 65 | Progressive inability to walk (HP:0002505) | 2.30809551 |
| 66 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.28360801 |
| 67 | Axonal loss (HP:0003447) | 2.28024410 |
| 68 | Incomplete penetrance (HP:0003829) | 2.23765730 |
| 69 | Lower limb muscle weakness (HP:0007340) | 2.21906564 |
| 70 | Limb hypertonia (HP:0002509) | 2.21395138 |
| 71 | Status epilepticus (HP:0002133) | 2.20229731 |
| 72 | Delusions (HP:0000746) | 2.20152369 |
| 73 | Neuronal loss in central nervous system (HP:0002529) | 2.20132408 |
| 74 | Amblyopia (HP:0000646) | 2.19730857 |
| 75 | Hemiparesis (HP:0001269) | 2.18174723 |
| 76 | Abnormality of the periventricular white matter (HP:0002518) | 2.18085320 |
| 77 | Epileptiform EEG discharges (HP:0011182) | 2.15595687 |
| 78 | Absent speech (HP:0001344) | 2.15042540 |
| 79 | Inability to walk (HP:0002540) | 2.12293633 |
| 80 | Abnormal atrioventricular conduction (HP:0005150) | 2.11180790 |
| 81 | Genetic anticipation (HP:0003743) | 2.08952953 |
| 82 | Abnormality of saccadic eye movements (HP:0000570) | 2.07656234 |
| 83 | Bundle branch block (HP:0011710) | 2.07541947 |
| 84 | Lower limb asymmetry (HP:0100559) | 2.05966272 |
| 85 | Increased cerebral lipofuscin (HP:0011813) | 2.05304923 |
| 86 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.03479341 |
| 87 | Abnormality of the corticospinal tract (HP:0002492) | 2.03246764 |
| 88 | Obstructive sleep apnea (HP:0002870) | 2.02832175 |
| 89 | Memory impairment (HP:0002354) | 2.02679064 |
| 90 | Insomnia (HP:0100785) | 1.99893296 |
| 91 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.99685702 |
| 92 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.99685702 |
| 93 | Spinal canal stenosis (HP:0003416) | 1.98416399 |
| 94 | Agitation (HP:0000713) | 1.98213305 |
| 95 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.98206416 |
| 96 | Onion bulb formation (HP:0003383) | 1.97571388 |
| 97 | Spastic tetraparesis (HP:0001285) | 1.97501468 |
| 98 | Apathy (HP:0000741) | 1.97388179 |
| 99 | Bowel incontinence (HP:0002607) | 1.97058405 |
| 100 | Neurofibrillary tangles (HP:0002185) | 1.95923189 |
| 101 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.94887307 |
| 102 | Truncus arteriosus (HP:0001660) | 1.94629811 |
| 103 | Obsessive-compulsive behavior (HP:0000722) | 1.93923711 |
| 104 | Inappropriate behavior (HP:0000719) | 1.93664722 |
| 105 | Rigidity (HP:0002063) | 1.90892339 |
| 106 | Dysphonia (HP:0001618) | 1.89230755 |
| 107 | Diminished motivation (HP:0000745) | 1.87733783 |
| 108 | EEG with generalized epileptiform discharges (HP:0011198) | 1.87551998 |
| 109 | Peripheral hypomyelination (HP:0007182) | 1.85925616 |
| 110 | Optic neuritis (HP:0100653) | 1.85080121 |
| 111 | Retrobulbar optic neuritis (HP:0100654) | 1.85080121 |
| 112 | Congenital stationary night blindness (HP:0007642) | 1.82483246 |
| 113 | Termporal pattern (HP:0011008) | 1.82377417 |
| 114 | Insidious onset (HP:0003587) | 1.82377417 |
| 115 | Cerebral inclusion bodies (HP:0100314) | 1.82023773 |
| 116 | Drooling (HP:0002307) | 1.81664944 |
| 117 | Excessive salivation (HP:0003781) | 1.81664944 |
| 118 | Abnormal large intestine physiology (HP:0012700) | 1.81199527 |
| 119 | Tetraplegia (HP:0002445) | 1.79978166 |
| 120 | Global brain atrophy (HP:0002283) | 1.79427131 |
| 121 | Hyperventilation (HP:0002883) | 1.78733009 |
| 122 | Generalized hypotonia (HP:0001290) | 1.77930437 |
| 123 | Hypsarrhythmia (HP:0002521) | 1.77633885 |
| 124 | Clumsiness (HP:0002312) | 1.77523024 |
| 125 | Decreased central vision (HP:0007663) | 1.76668144 |
| 126 | Abnormality of binocular vision (HP:0011514) | 1.76062353 |
| 127 | Diplopia (HP:0000651) | 1.76062353 |
| 128 | Acute lymphatic leukemia (HP:0006721) | 1.75941652 |
| 129 | Rapidly progressive (HP:0003678) | 1.72209632 |
| 130 | Myositis (HP:0100614) | 1.71074614 |
| 131 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.70778089 |
| 132 | Gait ataxia (HP:0002066) | 1.68573948 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 7.83540186 |
| 2 | NTRK3 | 3.99872828 |
| 3 | MAP3K9 | 3.63957740 |
| 4 | DAPK2 | 2.95424388 |
| 5 | KSR2 | 2.94109954 |
| 6 | RIPK4 | 2.87438139 |
| 7 | PRKD3 | 2.70872836 |
| 8 | CAMKK1 | 2.43156777 |
| 9 | MAP3K13 | 2.22669931 |
| 10 | FES | 2.17187087 |
| 11 | MINK1 | 2.05308449 |
| 12 | TAOK1 | 1.88590699 |
| 13 | NTRK1 | 1.85940960 |
| 14 | NTRK2 | 1.84587986 |
| 15 | ARAF | 1.83445131 |
| 16 | KSR1 | 1.77219374 |
| 17 | PAK6 | 1.76622464 |
| 18 | MAP3K4 | 1.72202622 |
| 19 | SIK2 | 1.64768808 |
| 20 | CDK5 | 1.58710574 |
| 21 | MARK1 | 1.56102206 |
| 22 | DAPK1 | 1.55583702 |
| 23 | MAP3K2 | 1.50250772 |
| 24 | TYRO3 | 1.49103582 |
| 25 | MAP3K11 | 1.48893549 |
| 26 | TNIK | 1.45139623 |
| 27 | CAMKK2 | 1.43520301 |
| 28 | TAOK3 | 1.31624750 |
| 29 | CASK | 1.30241078 |
| 30 | RAF1 | 1.27600142 |
| 31 | MAP4K1 | 1.22668377 |
| 32 | STK38 | 1.19473506 |
| 33 | PRPF4B | 1.17761772 |
| 34 | MAP2K7 | 1.12967212 |
| 35 | TXK | 1.12214354 |
| 36 | MAPK12 | 1.09181509 |
| 37 | PRKCH | 1.08529538 |
| 38 | FRK | 1.08007339 |
| 39 | PINK1 | 1.03714397 |
| 40 | PAK3 | 1.03180776 |
| 41 | SGK223 | 1.02993844 |
| 42 | SGK494 | 1.02993844 |
| 43 | OXSR1 | 0.99309894 |
| 44 | BMPR2 | 0.97019096 |
| 45 | SGK3 | 0.95943656 |
| 46 | SYK | 0.95639647 |
| 47 | MAP2K4 | 0.94782198 |
| 48 | ADRBK2 | 0.93749609 |
| 49 | SGK2 | 0.93681277 |
| 50 | MARK2 | 0.89661381 |
| 51 | CAMK1D | 0.89598413 |
| 52 | RIPK1 | 0.88160817 |
| 53 | NEK1 | 0.87058529 |
| 54 | STK11 | 0.86753570 |
| 55 | ALK | 0.86504679 |
| 56 | PDPK1 | 0.84257122 |
| 57 | SGK1 | 0.83058814 |
| 58 | UHMK1 | 0.82699956 |
| 59 | PDK1 | 0.80942060 |
| 60 | CDK15 | 0.79829858 |
| 61 | MAP3K1 | 0.79760371 |
| 62 | CDK18 | 0.79626389 |
| 63 | RET | 0.79193960 |
| 64 | PRKCG | 0.79146171 |
| 65 | TNK2 | 0.78503839 |
| 66 | DYRK1A | 0.77275694 |
| 67 | CAMK1 | 0.76032993 |
| 68 | TRIB3 | 0.75478139 |
| 69 | CDK14 | 0.75085742 |
| 70 | JAK1 | 0.73769288 |
| 71 | PKN1 | 0.72882682 |
| 72 | BLK | 0.71454409 |
| 73 | JAK2 | 0.70026438 |
| 74 | CDK11A | 0.69600932 |
| 75 | PTK2B | 0.68996924 |
| 76 | LMTK2 | 0.63896345 |
| 77 | CAMK2A | 0.63078204 |
| 78 | MAPK13 | 0.62340472 |
| 79 | ITK | 0.61458952 |
| 80 | GRK5 | 0.61012159 |
| 81 | MAP2K6 | 0.60176969 |
| 82 | CAMK2B | 0.58885511 |
| 83 | FYN | 0.58763972 |
| 84 | NEK6 | 0.56885379 |
| 85 | CAMK1G | 0.56833356 |
| 86 | MAP3K12 | 0.56734637 |
| 87 | PRKD2 | 0.55858293 |
| 88 | DAPK3 | 0.55045607 |
| 89 | BRSK1 | 0.53991806 |
| 90 | MAP2K1 | 0.52991940 |
| 91 | INSRR | 0.52932375 |
| 92 | PRKCZ | 0.52833512 |
| 93 | PRKCQ | 0.52639742 |
| 94 | MAPK4 | 0.51496668 |
| 95 | * RPS6KA3 | 0.50846815 |
| 96 | CAMK4 | 0.50786613 |
| 97 | MAPK10 | 0.50212083 |
| 98 | IRAK2 | 0.49051498 |
| 99 | HCK | 0.48140807 |
| 100 | DMPK | 0.47933362 |
| 101 | MOS | 0.47884966 |
| 102 | SCYL2 | 0.46367096 |
| 103 | MAPK7 | 0.45152998 |
| 104 | ACVR1B | 0.44102612 |
| 105 | WNK1 | 0.44056426 |
| 106 | MAP4K2 | 0.43577423 |
| 107 | GRK6 | 0.41710609 |
| 108 | MAP2K2 | 0.41476481 |
| 109 | HIPK2 | 0.39382625 |
| 110 | PHKG2 | 0.38024438 |
| 111 | PHKG1 | 0.38024438 |
| 112 | CDK19 | 0.37690514 |
| 113 | PRKG1 | 0.37374377 |
| 114 | CDC42BPA | 0.36604010 |
| 115 | TEC | 0.36545485 |
| 116 | TYK2 | 0.36537327 |
| 117 | LYN | 0.36536578 |
| 118 | PLK2 | 0.36003292 |
| 119 | RPS6KA2 | 0.34963997 |
| 120 | FGR | 0.34131194 |
| 121 | PRKCB | 0.34033332 |
| 122 | BMX | 0.32587097 |
| 123 | PDGFRA | 0.32351414 |
| 124 | MAP3K7 | 0.32087423 |
| 125 | BRAF | 0.30047438 |
| 126 | MAPK8 | 0.28612979 |
| 127 | PRKACG | 0.27435355 |
| 128 | CAMK2G | 0.26761134 |
| 129 | CSNK1A1 | 0.25617012 |
| 130 | FGFR2 | 0.25231451 |
| 131 | PRKD1 | 0.24304633 |
| 132 | CSNK1G2 | 0.23910815 |
| 133 | PRKCE | 0.23488811 |
| 134 | PRKCA | 0.23322784 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Olfactory transduction_Homo sapiens_hsa04740 | 3.36030241 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 2.73728156 |
| 3 | Circadian entrainment_Homo sapiens_hsa04713 | 2.73093082 |
| 4 | * Morphine addiction_Homo sapiens_hsa05032 | 2.72049147 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.71904949 |
| 6 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.71754481 |
| 7 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.68239265 |
| 8 | Cocaine addiction_Homo sapiens_hsa05030 | 2.67170498 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.55658995 |
| 10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.46420638 |
| 11 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.40824222 |
| 12 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.29327947 |
| 13 | Cholinergic synapse_Homo sapiens_hsa04725 | 2.26350780 |
| 14 | Salivary secretion_Homo sapiens_hsa04970 | 2.01996372 |
| 15 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.91582105 |
| 16 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.90362505 |
| 17 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.82039343 |
| 18 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.79536726 |
| 19 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.78778972 |
| 20 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.73225672 |
| 21 | Insulin secretion_Homo sapiens_hsa04911 | 1.70933638 |
| 22 | * Renin secretion_Homo sapiens_hsa04924 | 1.62522279 |
| 23 | Gap junction_Homo sapiens_hsa04540 | 1.59636466 |
| 24 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 1.54841969 |
| 25 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.50380481 |
| 26 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.49115062 |
| 27 | Long-term depression_Homo sapiens_hsa04730 | 1.47245446 |
| 28 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.40493641 |
| 29 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.34377286 |
| 30 | Glioma_Homo sapiens_hsa05214 | 1.28515368 |
| 31 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.28071937 |
| 32 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.18483654 |
| 33 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.17166399 |
| 34 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.08318498 |
| 35 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.07447623 |
| 36 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.04788716 |
| 37 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.02987442 |
| 38 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.01068617 |
| 39 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.98939764 |
| 40 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.96194048 |
| 41 | * Taste transduction_Homo sapiens_hsa04742 | 0.93049588 |
| 42 | Melanogenesis_Homo sapiens_hsa04916 | 0.90940847 |
| 43 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.90841618 |
| 44 | Alcoholism_Homo sapiens_hsa05034 | 0.90324909 |
| 45 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.87635312 |
| 46 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.87118196 |
| 47 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.85788531 |
| 48 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.83001551 |
| 49 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.82212161 |
| 50 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.81897019 |
| 51 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.81806641 |
| 52 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.80207722 |
| 53 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.79687766 |
| 54 | Phototransduction_Homo sapiens_hsa04744 | 0.79457171 |
| 55 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.78324012 |
| 56 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.78102840 |
| 57 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.77190414 |
| 58 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.77164895 |
| 59 | Axon guidance_Homo sapiens_hsa04360 | 0.75839964 |
| 60 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.74228405 |
| 61 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.73294264 |
| 62 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.73006426 |
| 63 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.72283565 |
| 64 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.72214985 |
| 65 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.71986887 |
| 66 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.71595240 |
| 67 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.69968594 |
| 68 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.68826366 |
| 69 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.68737490 |
| 70 | Tuberculosis_Homo sapiens_hsa05152 | 0.67514493 |
| 71 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.65277637 |
| 72 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.61810497 |
| 73 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.61627657 |
| 74 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.61253804 |
| 75 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.61230910 |
| 76 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.58302639 |
| 77 | Endocytosis_Homo sapiens_hsa04144 | 0.57791144 |
| 78 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.56904657 |
| 79 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.56277011 |
| 80 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.55488912 |
| 81 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.55420126 |
| 82 | Endometrial cancer_Homo sapiens_hsa05213 | 0.55371568 |
| 83 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.54401372 |
| 84 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.54397492 |
| 85 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.54233935 |
| 86 | Platelet activation_Homo sapiens_hsa04611 | 0.54064016 |
| 87 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.52567318 |
| 88 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.52501667 |
| 89 | Bile secretion_Homo sapiens_hsa04976 | 0.51974894 |
| 90 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.51718015 |
| 91 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.50685688 |
| 92 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.50544761 |
| 93 | Prion diseases_Homo sapiens_hsa05020 | 0.50143533 |
| 94 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.49845051 |
| 95 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.49266740 |
| 96 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.48290504 |
| 97 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46540376 |
| 98 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.46326875 |
| 99 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.45706931 |
| 100 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.44719640 |
| 101 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.44692769 |
| 102 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.44418635 |
| 103 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.43848209 |
| 104 | Leishmaniasis_Homo sapiens_hsa05140 | 0.43538423 |
| 105 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.42805600 |
| 106 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.42685980 |
| 107 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.41380170 |
| 108 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.41337177 |
| 109 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.41302759 |
| 110 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.40968318 |
| 111 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.40959168 |
| 112 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.40732024 |
| 113 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.40135401 |
| 114 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.40096917 |
| 115 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.38424084 |
| 116 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.37311302 |
| 117 | Thyroid cancer_Homo sapiens_hsa05216 | 0.36072188 |
| 118 | Circadian rhythm_Homo sapiens_hsa04710 | 0.36005089 |
| 119 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.35975830 |
| 120 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.35170925 |
| 121 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.33387037 |
| 122 | Lysosome_Homo sapiens_hsa04142 | 0.32656895 |
| 123 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.32342068 |
| 124 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.31700213 |
| 125 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.30441183 |

